Simulations Plus (SLP) Joins European Consortium on Development of Oral Bioavailability Tools (OrBiTo)
10/8/2012 10:09:09 AM
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has accepted an invitation and signed a formal agreement to participate in the European Union Oral Bioavailability Tools (OrBiTo) project. Simulations Plus is the only non-European company invited to participate.
comments powered by